Product Images Oxcarbazepine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 14 images provide visual information about the product associated with Oxcarbazepine NDC 72888-087 by Advagen Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Oxcarbazepine Tablets, USP - 150mg - 100's Tablets - NDC 72888-087-01 - oxcarbazepine tabs usp 150mg 100s

Oxcarbazepine Tablets, USP - 150mg - 100's Tablets - NDC 72888-087-01 - oxcarbazepine tabs usp 150mg 100s

This is a medication called Oxcarbazepine available in a film-coated tablet form containing 150mg of the drug. The usual dosage and other information can be found in the package insert. The tablets should be stored between 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F), in a tight, light-resistant container. The drug should be kept away from children. Each container consists of 100 tablets available only through a prescription. The medication guide is to be given to each patient by the pharmacist and is available online at www.advagenpharma.com/medguide/oxcarbazepinetablets. The drug is distributed by Advagen Pharma Limited of Plainsboro, NJ, and is manufactured in India by Rubicon Research Private Limited with an Mfg Lic No. : KD-682 21606.*

Oxcarbazepine Tablets, USP - 150mg - 30's Tablets - NDC 72888-087-30 - oxcarbazepine tabs usp 150mg 30s

Oxcarbazepine Tablets, USP - 150mg - 30's Tablets - NDC 72888-087-30 - oxcarbazepine tabs usp 150mg 30s

Each film-coated tablet of Bepune contains 150 mg of Oxcarbazepine. It should be dispensed in a tight, light-resistant container and stored at 20° to 25°C (68° to 77°F) out of the reach of children. The tablets are packaged in a container with 30 tablets and distributed by Advagen Pharma Limited. The manufacturer of the tablets is Rubicon Research Private Limited and the product is for prescription use only. The lot number of the drug is KD-682 21605 and the dosage is indicated as 150 mg of tablets USP. For further information, refer to the accompanying package insert and the website of the manufacturer at www.advagenpharma.com.*

Oxcarbazepine Tablets, USP - 150mg - 500's Tablets - NDC 72888-087-05 - oxcarbazepine tabs usp 150mg 500s

Oxcarbazepine Tablets, USP - 150mg - 500's Tablets - NDC 72888-087-05 - oxcarbazepine tabs usp 150mg 500s

Each film-coated tablet contains 150 mg of Oxcarbazepine. Store between 20° to 25°C (68° to 77°F) with permitted excursions to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Dispense in a tight light-resistant container [see USP]. Keep out of reach of children. The usual dosage is described in the package insert. The medication guide is available at www.advagenpharma.com/medguide/oxcarbazepinetablets. This is a prescription-only medicine in the form of Oxcarbazepine Tablets, USP, with a strength of 150 mg. It is dispensed in 500 Tablets and manufactured by Rubicon Research Private Limited in India. The accompanying medication guide should be available to each patient.*

Oxcarbazepine Tablets, USP - 300mg - 100's Tablets - NDC 72888-088-01 - oxcarbazepine tabs usp 300mg 100

Oxcarbazepine Tablets, USP - 300mg - 100's Tablets - NDC 72888-088-01 - oxcarbazepine tabs usp 300mg 100

Each tablet of Oxcarbazepine contains 300 mg. It should be stored at a temperature between 20°C to 25°C (68°F to 77°F) and excursions are permitted to 15°C to 30°C (59°F to 86°F). It should be dispensed in a light-resistant container and must be kept out of reach of children. Dosage information is available on the package insert. A medication guide is available at www.advagenpharma.com/medguide/oxcarbazepinetablets. The medicine is manufactured by Rubicon Research Private Limited, and distributed by Advagen Pharma Limited.*

Oxcarbazepine Tablets, USP - 300mg - 30's Tablets - NDC 72888-088-30 - oxcarbazepine tabs usp 300mg 30s

Oxcarbazepine Tablets, USP - 300mg - 30's Tablets - NDC 72888-088-30 - oxcarbazepine tabs usp 300mg 30s

Each tablet contains 300mg of Oxcarbazepine, manufactured by Rubicon Research in India and distributed by Advagen Pharma in the USA. It should be stored at 20-25°C in a child-resistant container. A medication guide is available at www.advagenpharma.com and should be provided to patients by the pharmacist. This is a prescription drug dispensed in a tight container.*

Oxcarbazepine Tablets, USP - 300mg - 500's Tablets - NDC 72888-088-05 - oxcarbazepine tabs usp 300mg 500s

Oxcarbazepine Tablets, USP - 300mg - 500's Tablets - NDC 72888-088-05 - oxcarbazepine tabs usp 300mg 500s

Each tablet contains 300 mg of Oxcarbazepine. The tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with excursions up to 15°C to 30°C (59°F to 86°F) permitted. It should be dispensed in a tightly closed, light-resistant container, and kept out of reach of children. Usual dosage instructions can be found in the package insert. The pharmacist should provide the Medication Guide to patients. The medication guide can be found at www.advagenpharma.com/medguide/oxcarbazepinetablets. The tablets are manufactured by Rubicon Research Private Limited, India and distributed by Advagen Pharma Limited in NJ, USA.*

Oxcarbazepine Tablets, USP - 600mg - 100's Tablets - NDC 72888-089-01 - oxcarbazepine tabs usp 600mg 100s

Oxcarbazepine Tablets, USP - 600mg - 100's Tablets - NDC 72888-089-01 - oxcarbazepine tabs usp 600mg 100s

Oxcarbazepine is a tablet that contains 600 mg of medication and should be stored at a temperature of 20°C to 25°C, with permitted excursions up to 15°C to 30°C. It should be dispensed in a tightly closed, light-resistant container. The usual dosage is mentioned in the package insert, and it is important to keep this and all other drugs out of the reach of children. This tablet is to be accompanied by a medication guide, dispensed to each patient by the pharmacist. The medication guide can be found online at www.advagenpharma.com/medguide/oxcarbazepinetablets. It is distributed by Advagen Pharma Limited, situated in Plainsboro, NJ, USA, and manufactured by Rubicon Research Private Limited in India. The manufacturing license number of the medication is KD-682 21619.*

Oxcarbazepine Tablets, USP - 600mg - 30's Tablets - NDC 72888-089-30 - oxcarbazepine tabs usp 600mg 30s

Oxcarbazepine Tablets, USP - 600mg - 30's Tablets - NDC 72888-089-30 - oxcarbazepine tabs usp 600mg 30s

This is a medication used to treat seizures. Each tablet contains 600mg of Oxcarbazepine. The tablets should be stored in a cool and dry place, away from children. Patients should see the package insert for dosage guidelines and a Medication guide is available from the manufacturer. The medication is distributed by Advagen Pharma, and manufactured by Rubicon Research Private limited in India.*

Oxcarbazepine Tablets, USP - 600mg - 500's Tablets - NDC 72888-089-05 - oxcarbazepine tabs usp 600mg 500

Oxcarbazepine Tablets, USP - 600mg - 500's Tablets - NDC 72888-089-05 - oxcarbazepine tabs usp 600mg 500

Each tablet of Oxcarbazepine contains 600 mg of the active ingredient. The tablets should be stored at a temperature range of 20°C to 25°C, with permissible excursions to 15°C to 30°C, in a tightly sealed container that protects from light. To ensure the safety of children, all medications should be kept out of their reach. Usual dosages should be obtained from the package insert. This medication is available only with a prescription. The manufacturer of this medication is Rubicon Research Private Limited in India, and it is distributed by Advagen Pharma Limited in Plainsboro, NJ, USA. A medication guide is available at www.advagenpharma.com/medguide/oxcarbazepinetablets.*

Figure 1 Kaplan-Meier Estimates of Exit Rate by Treatment Group. - oxcarbazepine tabs usp fig1

Figure 1 Kaplan-Meier Estimates of Exit Rate by Treatment Group. - oxcarbazepine tabs usp fig1

Figure 2 Kaplan-Meier Estimates of First Seizure Event Rate by Treatment Group. - oxcarbazepine tabs usp fig2

Figure 2  Kaplan-Meier Estimates of First Seizure Event Rate by Treatment Group. - oxcarbazepine tabs usp fig2

Figure 3 Kaplan-Meier Estimates of Exit Rate by Treatment Group. - oxcarbazepine tabs usp fig3

Figure 3  Kaplan-Meier Estimates of Exit Rate by Treatment Group. - oxcarbazepine tabs usp fig3

Figure 4 Kaplan-Meier Estimates of Exit Rate by Treatment Group. - oxcarbazepine tabs usp fig4

Figure 4  Kaplan-Meier Estimates of Exit Rate by Treatment Group. - oxcarbazepine tabs usp fig4

Oxcarbazepine structural formula. - oxcarbazepine tabs usp structural formula

Oxcarbazepine structural formula. - oxcarbazepine tabs usp structural formula

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.